Stenting of Symptomatic Atherosclerotic Lesions in the Vertebral or Intracranial Arteries (SSYLVIA)
Top Cited Papers
Open Access
- 1 June 2004
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Stroke
- Vol. 35 (6) , 1388-1392
- https://doi.org/10.1161/01.str.0000128708.86762.d6
Abstract
Background and Purpose— Stroke rates in patients with symptomatic intracranial stenosis may be as high as 10% to 24% per year on medical therapy. This multicenter, nonrandomized, prospective feasibility study evaluated the NEUROLINK System for treatment of vertebral or intracranial artery stenosis.Keywords
This publication has 13 references indexed in Scilit:
- Fate of Branch Arteries after Intracranial StentingNeurosurgery, 2003
- Acute-Phase Response after Stent Implantation in the Carotid Artery: Association with 6-month In-Stent RestenosisRadiology, 2003
- Angioplasty and stenting for primary treatment of intracranial arterial stenoses.Archives of Neurology, 2001
- Association of intracranial stenosis with cortical symptoms or signsNeurology, 2000
- Symptomatic intracranial atherosclerosisNeurology, 2000
- The Warfarin-Aspirin Symptomatic Intracranial Disease StudyNeurology, 1995
- Carotid endarterectomy for patients with asymptomatic internal carotid artery stenosisJournal of the Neurological Sciences, 1995
- Is transcranial Doppler a worthwhile addition to screening tests for cerebrovascular disease?Journal of Vascular Surgery, 1995
- Chinese‐white differences in the distribution of occlusive cerebrovascular diseaseNeurology, 1990
- Failure of Extracranial–Intracranial Arterial Bypass to Reduce the Risk of Ischemic StrokeNew England Journal of Medicine, 1985